10x Genomics, Inc.
As of Oct 15, 2026 close
- Market cap
- $9.41B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $11.62$102.81
- Volume (live)
- -
- Avg. volume (3M)
- 3.73M
10x Genomics (TXG) Stock Price & Financial Analysis
10x Genomics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $68.57 - $73.74 |
|---|---|
| 52-Week High | $102.81 |
| 52-Week Low | $11.62 |
| Open | $69.35 |
| Volume (last close) | 4.32M |
| Average Volume (3M) | 3.73M |
| Revenue (TTM) | 616.91M |
|---|---|
| Net Income (TTM) | -75.13M |
| Free Cash Flow (TTM) | 121.44M |
| EPS (TTM) | −$0.59 |
| Profit Margin | -12.18% |
| Operating Margin | -14.88% |
| Return on Equity (ROE) | -9.10% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 9.41B |
|---|---|
| Shares Outstanding | 129.98M |
| Price to Sales (P/S) | 15.25 |
| Price to Book (P/B) | 11.40 |
| EV/EBITDA | 269.38 |
| 50-Day MA | $69.91 |
|---|---|
| 200-Day MA | $37.26 |
| 1-Year Change | +484.73% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
10x Genomics at a Glance
As of the Oct 15, 2026 close, 10x Genomics (TXG) has a market capitalization of $9.41B. The stock trades at 15.3× sales. Over the trailing twelve months it lost $75.13M on revenue of $616.91M and generated $121.44M of free cash flow. Revenue fell 4.3% year over year.
As of its latest reported balance sheet, it holds $502.51M in cash and securities against $78.80M of debt, a net cash position of $423.72M.
10x Genomics does not currently pay a dividend.
The share price is up 484.7% over the past year. At $72.39 (the Oct 15, 2026 close) it sits within its 52-week range of $11.62 to $102.81, above its 200-day moving average of $37.26.
Based on 17 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $69.71, 3.7% below the Oct 15, 2026 close.
Frequently Asked Questions About 10x Genomics
What is the current stock price for TXG?
As of the Oct 15, 2026 close, TXG stock trades at $72.39. The 52-week range is $11.62–$102.81, with a day range of $68.57–$73.74.
What is the P/E ratio for TXG?
The P/E ratio (Price-to-Earnings) for TXG is shown in the Key Statistics section. This valuation metric helps compare 10x Genomics, Inc. to industry peers.
Does TXG pay dividends?
10x Genomics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TXG?
Based on ratings from 17 professional analysts over the last 90 days, the consensus for TXG is Hold. The average 12-month price target is $69.71, a 3.7% downside from the Oct 15, 2026 close of $72.39.
What is the market cap of TXG?
As of the Oct 15, 2026 close, 10x Genomics's market capitalization is $9.41B, classifying it as a mid-cap company. 10x Genomics operates in the Healthcare sector within the Health Information Services industry.